MY157168A - Treatment using reprogrammed mature adult cells - Google Patents

Treatment using reprogrammed mature adult cells

Info

Publication number
MY157168A
MY157168A MYPI2012001348A MYPI20121348A MY157168A MY 157168 A MY157168 A MY 157168A MY PI2012001348 A MYPI2012001348 A MY PI2012001348A MY PI20121348 A MYPI20121348 A MY PI20121348A MY 157168 A MY157168 A MY 157168A
Authority
MY
Malaysia
Prior art keywords
cells
patient
retrodifferentiated
transdifferentiated
treatment
Prior art date
Application number
MYPI2012001348A
Inventor
Abuljadayel Ilham Mohamed Saleh Saeed
Original Assignee
Tristem Trading Cyprus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tristem Trading Cyprus Ltd filed Critical Tristem Trading Cyprus Ltd
Priority to MYPI2012001348A priority Critical patent/MY157168A/en
Publication of MY157168A publication Critical patent/MY157168A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A METHOD OF TREATING VARIOUS DISEASES, DISORDERS, OR CONDITIONS IN PATIENT USING REPROGRAMMED CELLS SUCH AS RETRODIFFERENTIATED, TRANSDIFFERENTIATED, OR REDIFFERENTIATED CELLS. THE METHOD COMPRISES OBTAINING COMMITTED CELLS FROM THE PATIENT, RETRODIFFERENTIATING THE COMMITTED CELLS TO OBTAIN RETRODIFFERENTIATED TARGET CELLS, AND ADMINISTERING THE RETRODIFFERENTIATED CELLS TO THE PATIENT. IN CERTAIN EMBODIMENTS, THE METHOD COMPRISES OBTAINING COMMITTED CELLS FROM THE PATIENT, TRANSDIFFERENTIATING THE COMMITTED CELLS TO OBTAIN TRANSDIFFERENTIATED TARGET CELLS, AND ADMINISTERING THE TRANSDIFFERENTIATED TARGET CELLS TO THE PATIENT. THE RETRODIFFERENTIATED OR TRANSDIFFERENTIATED TARGET CELLS REPAIR OR REPLENISH TISSUE OR CELLS IN THE PATIENT.
MYPI2012001348A 2009-10-19 2009-10-19 Treatment using reprogrammed mature adult cells MY157168A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2012001348A MY157168A (en) 2009-10-19 2009-10-19 Treatment using reprogrammed mature adult cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2012001348A MY157168A (en) 2009-10-19 2009-10-19 Treatment using reprogrammed mature adult cells

Publications (1)

Publication Number Publication Date
MY157168A true MY157168A (en) 2016-05-13

Family

ID=56362869

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012001348A MY157168A (en) 2009-10-19 2009-10-19 Treatment using reprogrammed mature adult cells

Country Status (1)

Country Link
MY (1) MY157168A (en)

Similar Documents

Publication Publication Date Title
TN2012000157A1 (en) Treatment using reprogrammed mature adult cells
IL260117A (en) Treatment of diseases, disorders or conditions of the lung using placental cells
MX2019005130A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin.
TR201911199T4 (en) Treatment to increase cell growth.
WO2012071526A3 (en) Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
WO2007131232A8 (en) Compositions and their uses directed to ptpr alpha
MX2011009751A (en) Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2.
EP2365816A4 (en) Composition comprising mesenchymal stem cells or culture solution of mesenchymal stem cells for the prevention or treatment of neural diseases
WO2011079261A3 (en) Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
WO2011130675A3 (en) Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof
MX2013002381A (en) Bone marrow derived cd271 precursor cells for cardiac repair.
WO2011038205A3 (en) Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh
NZ607195A (en) Methods for treating and/or reversing neurodegenerative diseases and/or disorders
WO2013078376A3 (en) Isoxazole treatments for diabetes
MX354667B (en) Methods for treating a stroke-related sensorimotor impairment using aminopyridines.
MY157168A (en) Treatment using reprogrammed mature adult cells
MX356814B (en) Methods and compositions for neuroprotection.
WO2013033165A3 (en) Compositions, kits and methods for treating obesity, diabetes and hyperglycemia
PL2470213T3 (en) Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
WO2012177565A3 (en) Regulation of macrophage activation using mir - 125b
AR073910A1 (en) TREATMENT OF DIFFERENT DISEASES, USING REPROGRAMED MATURE ADULT CELLS.
EP2049656A4 (en) Use of late passage mesenchymal stem cells (mscs) for treatment of cardiac rhythm disorders
UY32186A (en) TREATMENT USING REPROGRAMED MATURE ADULT CELLS
TR201204532T1 (en) Treatment using re-programmed mature adult cells.
WO2010110602A3 (en) Method for regenerating dopaminergic neurons in the substantia nigra pars compacta using human adult stem cells or precursor cells